Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine

The feline immunodeficiency virus (FIV) vaccine called Fel-O-Vax(®) FIV is the first commercial FIV vaccine released worldwide for the use in domestic cats against global FIV subtypes (A–E). This vaccine consists of inactivated dual-subtype (A plus D) FIV-infected cells, whereas its prototype vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahay, Bikash, Yamamoto, Janet K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977270/
https://www.ncbi.nlm.nih.gov/pubmed/29789450
http://dx.doi.org/10.3390/v10050277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977270/
https://www.ncbi.nlm.nih.gov/pubmed/29789450
http://dx.doi.org/10.3390/v10050277

Ejemplares similares